BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33032712)

  • 1. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus.
    Ndrepepa G; Kastrati A; Menichelli M; Neumann FJ; Wöhrle J; Bernlochner I; Richardt G; Witzenbichler B; Sibbing D; Gewalt S; Angiolillo DJ; Hamm CW; Hapfelmeier A; Trenk D; Laugwitz KL; Schunkert H; Schüpke S; Mayer K
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2238-2247. PubMed ID: 33032712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial.
    Behnes M; Lahu S; Ndrepepa G; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Gewalt S; Witzenbichler B; Hochholzer W; Sibbing D; Cassese S; Angiolillo DJ; Hemetsberger R; Valina C; Müller A; Kufner S; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Joner M; Fusaro M; Richardt G; Laugwitz KL; Neumann FJ; Schunkert H; Schüpke S; Kastrati A; Akin I
    Clin Res Cardiol; 2023 Apr; 112(4):518-528. PubMed ID: 35789430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 Trial.
    Lahu S; Scalamogna M; Ndrepepa G; Menichelli M; Valina C; Hemetsberger R; Witzenbichler B; Bernlochner I; Joner M; Xhepa E; Hapfelmeier A; Kufner S; Sager HB; Mayer K; Kessler T; Laugwitz KL; Richardt G; Schunkert H; Neumann FJ; Kastrati A; Cassese S
    J Am Heart Assoc; 2022 Dec; 11(24):e027257. PubMed ID: 36515247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk.
    Lahu S; Presch A; Ndrepepa G; Menichelli M; Valina C; Hemetsberger R; Witzenbichler B; Bernlochner I; Joner M; Xhepa E; Hapfelmeier A; Kufner S; Rifatov N; Sager HB; Mayer K; Kessler T; Laugwitz KL; Richardt G; Schunkert H; Neumann FJ; Sibbing D; Angiolillo DJ; Kastrati A; Cassese S
    Circ Cardiovasc Interv; 2022 Oct; 15(10):e012204. PubMed ID: 36256695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes.
    Lahu S; Ndrepepa G; Gewalt S; Schüpke S; Pellegrini C; Bernlochner I; Aytekin A; Neumann FJ; Menichelli M; Richardt G; Cassese S; Xhepa E; Kufner S; Sager HB; Joner M; Ibrahim T; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A; Mayer K
    Int J Cardiol; 2021 Sep; 338():8-13. PubMed ID: 34126130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    Valina C; Neumann FJ; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Aytekin A; Richardt G; Witzenbichler B; Sibbing D; Cassese S; Angiolillo DJ; Kufner S; Liebetrau C; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Wustrow I; Joner M; Trenk D; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    J Am Coll Cardiol; 2020 Nov; 76(21):2436-2446. PubMed ID: 33213722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.
    Coughlan JJ; Aytekin A; Lahu S; Ndrepepa G; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Gewalt S; Witzenbichler B; Hochholzer W; Sibbing D; Cassese S; Angiolillo DJ; Hemetsberger R; Valina C; Müller A; Kufner S; Liebetrau C; Xhepa E; Hapfelmeier A; Sager HB; Joner M; Fusaro M; Richardt G; Laugwitz KL; Neumann FJ; Schunkert H; Schüpke S; Kastrati A
    JAMA Cardiol; 2021 Oct; 6(10):1121-1129. PubMed ID: 34190967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial.
    Gewalt S; Lahu S; Ndrepepa G; Pellegrini C; Bernlochner I; Neumann FJ; Menichelli M; Morath T; Witzenbichler B; Wöhrle J; Hoppe K; Richardt G; Laugwitz KL; Schunkert H; Kastrati A; Schüpke S; Mayer K
    J Atheroscler Thromb; 2022 May; 29(5):747-761. PubMed ID: 33867409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Aytekin A; Ndrepepa G; Neumann FJ; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Lahu S; Richardt G; Witzenbichler B; Sibbing D; Cassese S; Angiolillo DJ; Valina C; Kufner S; Liebetrau C; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Wustrow I; Joner M; Trenk D; Fusaro M; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    Circulation; 2020 Dec; 142(24):2329-2337. PubMed ID: 33115278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.
    Hemetsberger R; Richardt G; Lahu S; Valina C; Menichelli M; Abdelghani M; Wöhrle J; Toelg R; Witzenbichler B; Mankerious N; Liebetrau C; Bernlochner I; Hamm CW; Allali A; Joner M; Fusaro M; Xhepa E; Hapfelmeier A; Kufner S; Sager HB; Schüpke S; Laugwitz KL; Schunkert H; Neumann FJ; Kastrati A; Cassese S
    Cardiovasc Revasc Med; 2022 Aug; 41():122-128. PubMed ID: 35045943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate.
    Wöhrle J; Seeger J; Lahu S; Mayer K; Bernlochner I; Gewalt S; Menichelli M; Witzenbichler B; Hochholzer W; Sibbing D; Cassese S; Angiolillo DJ; Hemetsberger R; Valina C; Kufner S; Xhepa E; Hapfelmeier A; Sager HB; Joner M; Richardt G; Laugwitz KL; Neumann FJ; Schunkert H; Schüpke S; Kastrati A; Ndrepepa G
    JACC Cardiovasc Interv; 2021 Sep; 14(17):1857-1866. PubMed ID: 34446390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    Schüpke S; Neumann FJ; Menichelli M; Mayer K; Bernlochner I; Wöhrle J; Richardt G; Liebetrau C; Witzenbichler B; Antoniucci D; Akin I; Bott-Flügel L; Fischer M; Landmesser U; Katus HA; Sibbing D; Seyfarth M; Janisch M; Boncompagni D; Hilz R; Rottbauer W; Okrojek R; Möllmann H; Hochholzer W; Migliorini A; Cassese S; Mollo P; Xhepa E; Kufner S; Strehle A; Leggewie S; Allali A; Ndrepepa G; Schühlen H; Angiolillo DJ; Hamm CW; Hapfelmeier A; Tölg R; Trenk D; Schunkert H; Laugwitz KL; Kastrati A;
    N Engl J Med; 2019 Oct; 381(16):1524-1534. PubMed ID: 31475799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial.
    Menichelli M; Neumann FJ; Ndrepepa G; Mayer K; Wöhrle J; Bernlochner I; Richardt G; Witzenbichler B; Sibbing D; Gewalt S; Angiolillo DJ; Lahu S; Hamm CW; Hapfelmeier A; Trenk D; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    Ann Intern Med; 2020 Sep; 173(6):436-444. PubMed ID: 32687741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial.
    Coughlan JJ; Aytekin A; Ndrepepa G; Schüpke S; Bernlochner I; Mayer K; Neumann FJ; Menichelli M; Richardt G; Wöhrle J; Xhepa E; Kufner S; Sager HB; Joner M; Ibrahim T; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A; Cassese S
    Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(10):1117-1124. PubMed ID: 34468709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trial.
    Schulz S; Angiolillo DJ; Antoniucci D; Bernlochner I; Hamm C; Jaitner J; Laugwitz KL; Mayer K; von Merzljak B; Morath T; Neumann FJ; Richardt G; Ruf J; Schömig G; Schühlen H; Schunkert H; Kastrati A;
    J Cardiovasc Transl Res; 2014 Feb; 7(1):91-100. PubMed ID: 24371012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trial.
    Lahu S; Ndrepepa G; Neumann FJ; Menichelli M; Bernlochner I; Richardt G; Wöhrle J; Witzenbichler B; Hemetsberger R; Mayer K; Akin I; Cassese S; Gewalt S; Xhepa E; Kufner S; Valina C; Sager HB; Joner M; Ibrahim T; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):687-694. PubMed ID: 35191982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.
    Lee KS; Park KH; Park KW; Rha SW; Hwang D; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Lee NH; Rhew JY; Chun KJ; Lim YH; Bong JM; Bae JW; Lee BK; Kim SY; Shin WY; Lim HS; Park K; Kim HS
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):262-270. PubMed ID: 36715152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
    Aytekin A; Coughlan JJ; Ndrepepa G; Cassese S; Lahu S; Kufner S; Mayer K; Xhepa E; Gewalt S; Joner M; Hapfelmeier A; Angiolillo DJ; Menichelli M; Richardt G; Neumann FJ; Schunkert H; Kastrati A
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):231-239. PubMed ID: 36434779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study.
    Jin C; Kim MH; Bang J; Serebruany V
    Cardiology; 2017; 138(4):201-206. PubMed ID: 28810251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.